Literature DB >> 25650712

ASSOCIATION BETWEEN NEEDLE SIZE, POSTINJECTION REFLUX, AND INTRAOCULAR PRESSURE SPIKES AFTER INTRAVITREAL INJECTIONS.

Claudine E Pang1, Sarah Mrejen, Quan V Hoang, John A Sorenson, K Bailey Freund.   

Abstract

PURPOSE: To compare the effect of 30-gauge versus 32-gauge needle size on postinjection reflux and immediate postinjection intraocular pressure (IOP(immed_post)) spikes in eyes injected with anti-vascular endothelial growth factor agents.
METHODS: This was a prospective interventional case series of 65 eyes of 54 consecutive patients in a clinical practice setting who received intravitreal anti-vascular endothelial growth factor therapy. All eyes had preinjection IOP, IOP(immed_post), postinjection reflux, and axial lengths recorded.
RESULTS: There was a higher incidence of postinjection reflux in eyes injected with 30-gauge (53%) compared with those injected with 32-gauge (13%, P = 0.0007). Among 34 eyes injected with 30-gauge, 16 eyes without appreciable postinjection reflux had mean IOP(immed_post) of 44.3 ± 7.48 mmHg and mean IOP(immed_post) elevation of 29.6 ± 2.10 mmHg, which was significantly higher than the 18 eyes with reflux (mean IOP(immed_post) of 18.8 ± 7.15 mmHg and mean IOP(immed_post) elevation of 4.5 ± 1.74 mmHg, P < 0.0001). Among 31 eyes injected with 32-gauge, 27 eyes without appreciable postinjection reflux had mean IOP(immed_post) of 44.4 ± 10.82 mmHg and mean IOP(immed_post) elevation of 29.5 ± 1.99 mmHg, which was significantly higher than the 4 eyes with reflux (mean IOP(immed_post) of 21.3 ± 8.54 mmHg and mean IOP(immed_post) elevation of 9.5 ± 4.05 mmHg, P < 0.001). The differences in reflux and IOP between the two groups were unrelated to axial lengths (P = 0.451).
CONCLUSION: Eyes receiving injections with 32-gauge needles had a lower incidence of postinjection reflux and higher mean IOP immediately after injection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25650712     DOI: 10.1097/IAE.0000000000000476

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  10 in total

1.  Intraocular Pressure Changes Following Intravitreal Melphalan and Topotecan for the Treatment of Retinoblastoma With Vitreous Seeding.

Authors:  Matthew D Karl; Jasmine H Francis; Saipriya Iyer; Brian Marr; David H Abramson
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2017-01-17       Impact factor: 1.402

2.  Reflux, Intraocular Pressure Variation and Pain Following Intravitreal Ranibizumab Injections Using 30-Gauge or 32-Gauge Needles for Patients With Retinal Pathologies: A Randomized Clinical Trial.

Authors:  Saeed T Alshahrani; Uriel Rubin; Vasudha Gupta; Tom Gonder; Sanjay Sharma
Journal:  Cureus       Date:  2021-04-06

Review 3.  Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review.

Authors:  Rohan Merani; Alex P Hunyor
Journal:  Int J Retina Vitreous       Date:  2015-07-21

4.  Intravitreal infusion: A novel approach for intraocular drug delivery.

Authors:  Jiao Tian; Jia Liu; Xiao Liu; Yangyan Xiao; Luosheng Tang
Journal:  Sci Rep       Date:  2016-11-25       Impact factor: 4.379

5.  Intravitreal Injections of Bevacizumab: The Impact of Needle Size in Intraocular Pressure and Pain.

Authors:  Mónica Loureiro; Rita Matos; Paula Sepulveda; Dália Meira
Journal:  J Curr Glaucoma Pract       Date:  2017-08-05

6.  Real-time measurement of intraocular pressure variation during automatic intravitreal injections: An ex-vivo experimental study using porcine eyes.

Authors:  Ikjong Park; Han Sang Park; Hong Kyun Kim; Wan Kyun Chung; Keehoon Kim
Journal:  PLoS One       Date:  2021-08-26       Impact factor: 3.240

7.  Intravitreal Injections with Vascular Endothelial Growth Factor Inhibitors: A Practical Approach.

Authors:  Anne-Sofie Petri; Kirstine Boysen; Lasse J Cehofski; Elon H C van Dijk; Chantal Dysli; Josefine Fuchs; Rodolfo Mastropasqua; Yousif Subhi
Journal:  Ophthalmol Ther       Date:  2020-02-07

8.  Vitreous Reflux Frequency and Intraocular Pressure After First-Time Intravitreal Aflibercept Injections: Comparison of 30- and 32-Gauge Needles.

Authors:  Tetsuya Muto; Shigeki Machida
Journal:  Clin Ophthalmol       Date:  2020-03-03

Review 9.  Treatment-Emergent Adverse Events in Gene Therapy Trials for Inherited Retinal Diseases: A Narrative Review.

Authors:  Yan Nuzbrokh; Alexis S Kassotis; Sara D Ragi; Ruben Jauregui; Stephen H Tsang
Journal:  Ophthalmol Ther       Date:  2020-08-01

10.  Acute and subacute macular and peripapillary angiographic changes in choroidal and retinal blood flow post-intravitreal injections.

Authors:  Nadhini Arumuganathan; Maximilian Robert Justus Wiest; Mario Damiano Toro; Timothy Hamann; Katrin Fasler; Sandrine Anne Zweifel
Journal:  Sci Rep       Date:  2021-09-29       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.